vimarsana.com

Page 39 - டெக்சாஸ் தொழில்நுட்பம் பல்கலைக்கழகம் ஆரோக்கியம் அறிவியல் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Toci and COVID; Exercise for Arthritic Knees; It s TTHealthWatch!

Rick Lange: Do people with COVID benefit from a blood thinner? Elizabeth: A really exhaustive look so far at the human gut microbiome and how it may be related to disease. Rick: And a different anti-inflammatory medication for people with COVID and respiratory problems. Elizabeth: That s what we re talking about this week on TT HealthWatch, your weekly look at the medical headlines from Texas Tech University Health Sciences Center in El Paso. I m Elizabeth Tracey, a Baltimore-based medical journalist. Rick: And I m Rick Lange, president of the Texas Tech University Health Sciences Center in El Paso, where I m also the dean of the Paul L. Foster School of Medicine.

FDA Advisors Unconvinced by Lutonix BTK Drug-Coated Balloon

February 18, 2021 Despite having no significant safety concerns, an advisory panel to the US Food and Drug Administration said yesterday that it could not find enough evidence of efficacy and benefit to recommend premarket approval (PMA) of a below-the-knee drug-coated balloon (DCB) for the treatment of PAD. After a full day of discussion, the Circulatory Devices Panel of the Medical Devices Advisory Committee voted 15-2 (with one member abstaining) that reasonable assurance of safety was demonstrated for the DCB, made by Lutonix, a subsidiary of Becton, Dickinson and Company (BD). On the question of reasonable assurance of efficacy, however, the vote was the same 15-2 (with one member abstaining) that efficacy was not demonstrated. Similarly, on the question of whether the panel believed that the benefits outweighed the risks, the vote was 14-3 (with one member abstaining) that they did not.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.